Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Biochim Biophys Acta Rev Cancer ; 1874(2): 188410, 2020 12.
Artículo en Inglés | MEDLINE | ID: mdl-32827579

RESUMEN

Overexpression of the MYC oncogene is a molecular hallmark of both cancer initiation and progression. Targeting MYC is a logical and effective cancer therapeutic strategy. A special DNA secondary structure, the G-quadruplex (G4), is formed within the nuclease hypersensitivity element III1 (NHE III1) region, located upstream of the MYC gene's P1 promoter that drives the majority of its transcription. Targeting such G4 structures has been a focus of anticancer therapies in recent decades. Thus, a comprehensive review of the MYC G4 structure and its role as a potential therapeutic target is timely. In this review, we first outline the discovery of the MYC G4 structure and evidence of its formation in vitro and in cells. Then, we describe the functional role of G4 in regulating MYC gene expression. We also summarize three types of MYC G4-interacting proteins that can promote, stabilize and unwind G4 structures. Finally, we discuss G4-binding molecules and the anticancer activities of G4-stabilizing ligands, including small molecular compounds and peptides, and assess their potential as novel anticancer therapeutics.


Asunto(s)
Neoplasias/genética , Proteínas Proto-Oncogénicas c-myc/química , Proteínas Proto-Oncogénicas c-myc/genética , Bibliotecas de Moléculas Pequeñas/farmacología , Sitios de Unión , G-Cuádruplex/efectos de los fármacos , Regulación Neoplásica de la Expresión Génica , Humanos , Ligandos , Neoplasias/tratamiento farmacológico , Regiones Promotoras Genéticas/efectos de los fármacos , Proteínas Proto-Oncogénicas c-myc/metabolismo , Bibliotecas de Moléculas Pequeñas/uso terapéutico , Regulación hacia Arriba
2.
J Phys Chem Lett ; 9(3): 570-576, 2018 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-29338246

RESUMEN

The prevalent catalysts for natural and artificial N2 fixation are known to hinge upon transition-metal (TM) elements. Herein, we demonstrate by density functional theory that Al-doped graphene is a potential non-TM catalyst to convert N2 to NH3 in the presence of relatively mild proton/electron sources. In the integrated structure of the catalyst, the Al atom serves as a binding site and catalytic center while the graphene framework serves as an electron buffer during the successive proton/electron additions to N2 and its various downstream NxHy intermediates. The initial hydrogenation of N2 can readily take place via an internal H-transfer process with the assistance of a Li+ ion as an additive. In view of the recurrence of H transfer in the first step of N2 reduction observed in biological nitrogenases and other synthetic catalysts, this finding highlights the significance of heteroatom-assisted H transfer in the design of synthetic catalysts for N2 fixation.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA